Xcellerex Begins Construction on New FlexFactory Biomanufacturing Facility
Xcellerex, Inc. has begun construction of a state-of-the-art current good manufacturing practices-compliant FlexFactory biomanufacturing facility at its headquarters in Marlborough, MA.
Xcellerex, Inc. has begun construction of a state-of-the-art current good manufacturing practices-compliant FlexFactory biomanufacturing facility at its headquarters in Marlborough, MA. Construction will be completed in September 2010.
The facility, the second FlexFactory at the Marlborough site, will expand Xcellerex's capacity to provide bridge biomanufacturing services for clients that are planning or building their own FlexFactory facilities. The plant also will support Xcellerex's contract manufacturing operations. The new facility will feature 2,000 L Xcellerex XDR single-use bioreactors and modular single-use downstream unit operations through bulk-product.
Xcellerex's FlexFactory is a portable manufacturing platform, based on the application of single-use technologies, controlled environmental modules, and process automation including electronic batch records.
The Solution Lies with SOLBIOTE™: Achieving Sustainability, a Growing Focus in Biopharma
October 28th 2024The nexus between biopharmaceuticals and sustainability is seemingly far apart, however, it is increasingly recognized as an inevitable challenge. It is encouraged to take a sustainable approach to reducing the environmental impact of the production and supply of medicines while improving people's health; delivering the well-being of people and the planet. Yosuke Shimojo (Technical Value Support Section Manager, Nagase Viita) will unveil how SOLBIOTE™, a portfolio of injectable-grade saccharide excipients, would be a key for the biopharmaceutical development and achieving sustainability for a better future of the industry.
